New Intravenous Anaesthetics and Neuromuscular Blocking Drugs
@article{Reilly2012NewIA, title={New Intravenous Anaesthetics and Neuromuscular Blocking Drugs}, author={Charles S. Reilly and Walter S. Nimmo}, journal={Drugs}, year={2012}, volume={34}, pages={98-135} }
SummaryThe newer neuromuscular blocking drugs include vecuronium and atracurium. Vecuronium is a competitive neuromuscular blocking drug with a steroid nucleus. A dose of 0.1 mg/kg has an onset time of 2 minutes and provides surgical paralysis for 20 minutes. Recovery to 90% twitch height occurs in 40 to 50 minutes. Vecuronium has few adverse effects and its use is associated with cardiovascular stability. Atracurium is a competitive neuromuscular blocking drug which undergoes Hofmann…
4 Citations
Effect of dexmedetomidine with or without butorphanol on the clinico-physiological and haemodynamic stability in dogs undergoing ovariohysterectomy in midazolam and ketamine anaesthesia
- Medicine, Biology
- 2015
Addition of butorphanol did not have significant effects on the clinico-physiological and haemodynamic stability; however, it reduced the amount of ketamine required for maintenance and better sedation.
Safety of intravenous and inhalation anesthetics
- Medicine
- 2013
Determination of Minimal Alveolar Anesthetic Concentration (MAC) and Safety Margin of Inhalation Anesthetics are determined.
Full-Cost Determination of Different Levels of Care in the Intensive Care Unit
- MedicinePharmacoEconomics
- 2012
The analysis revealed a marked increase in patient-minute cost associated with mechanical ventilation, which has important economic implications with respect to selection of an appropriate neuromuscular blocking agent.
References
SHOWING 1-10 OF 404 REFERENCES
The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study.
- Medicine, BiologyBritish journal of anaesthesia
- 1980
Org NC 45 appears to be approximately as potent as pancuronium, but has a more rapid onset of action, considerably shorter duration of action and faster recovery rate than Pancuronium and represents a potentially valuable addition to the armamentarium of clinically useful muscle relaxants.
Verapamil and reversal of vecuronium neuromuscular blockade.
- Medicine, BiologyAnesthesia and analgesia
- 1984
The present case report deals with the prolonged effect of vecuronium bromide in a patient with renal insufficiency treated for supraventricular tachycardia with the calcium entry blocker verapamil.
Evaluation of atracurium in anaesthetized man.
- Medicine, BiologyBritish journal of anaesthesia
- 1981
The course of action of atracurium was appreciably shorter than that of other recognized competitive blocking agents and provided adequate relaxation during surgical intervention for 15--45 min; spontaneous recovery without the use of neostigmine was observed in some patients.
Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
- Medicine, BiologyBritish journal of anaesthesia
- 1983
The neuromuscular blocking properties of vecuronium (Org NC 45) and pancuronium were compared in 40 patients during halothane anaesthesia. Onset time was found to be dose-dependent, but no…
Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant
- Medicine, BiologyAnesthesia and analgesia
- 1982
Atracurium spontaneously decomposes at physiologic pH via the Hofmann elimination reaction and may also undergo ester hydrolysis independent of plasma cholinesterase, which may explain the lack of cumulative effect and the drug's intermediate duration of action.
Clinical comparison of atracurium and vecuronium (Org NC 45).
- Medicine, BiologyBritish journal of anaesthesia
- 1983
Both vecuronium and atracurium would appear to have certain advantages over existing non-depolarizing neuromuscular blocking drugs.
Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
- MedicineBritish journal of anaesthesia
- 1983
Comparative patterns of recovery during successive doses of three new, relatively non-cumulative, intermediate-duration non-depolarizing neuromuscular blocking drugs, BW A444U, atracurium and vecuronium, were studied in 94 surgical patients and suggest that the cumulative properties of the new drugs may be ranked as follows.
Neuromuscular Effects of Atracurium in Man
- Medicine, BiologyAnesthesia and analgesia
- 1982
The neuromuscular effects of atracurium were studied in class I or II patients anesthetized by a N2O-O2narcotic technique and the block could be antagonized by the common clinical combination of atropine and neostigmine.
Atracurium for intubation in man
- Medicine
- 1983
Atracurium may be a suitable alternative to suxamethonium when speed of intubation is not critical, and conditions were excellent in 80% of patients 1 minute after suxmethonia.
Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
- Medicine, BiologyBritish journal of anaesthesia
- 1986
The results show that profound neuromuscular blockade cannot be rapidly antagonized by either of these two agents, but if reversal is required under these circumstances, neostigmine would be the more effective drug.